306 filings
Page 5 of 16
4
DMAC
DiaMedica Therapeutics Inc
8 Dec 22
DiaMedica Therapeutics / Randall Michael Giuffre ownership change
4:55pm
SC 13G/A
Private AB TomEqt
6 Dec 22
DiaMedica Therapeutics / TomEqt Private AB ownership change
4:06pm
4
Private AB TomEqt
6 Dec 22
DiaMedica Therapeutics / AB TomEnterprise ownership change
3:19pm
4
Pilnik Richard D.
5 Dec 22
DiaMedica Therapeutics / Richard D. Pilnik ownership change
4:16pm
4
Giuffre Randall Michael
5 Dec 22
DiaMedica Therapeutics / Randall Michael Giuffre ownership change
4:08pm
4
DMAC
DiaMedica Therapeutics Inc
1 Dec 22
DiaMedica Therapeutics / Randall Michael Giuffre ownership change
5:11pm
4
DMAC
DiaMedica Therapeutics Inc
16 Nov 22
DiaMedica Therapeutics / Dietrich John Pauls ownership change
8:56pm
10-Q
2022 Q3
DMAC
DiaMedica Therapeutics Inc
Quarterly report
9 Nov 22
4:21pm
8-K
DMAC
DiaMedica Therapeutics Inc
9 Nov 22
DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2022 Financial Results
4:20pm
8-K
DMAC
DiaMedica Therapeutics Inc
26 Oct 22
DiaMedica Therapeutics Provides Update on ReMEDy2 Trial
4:30pm
4
DMAC
DiaMedica Therapeutics Inc
15 Sep 22
DiaMedica Therapeutics / Julie VanOrsdel Daves ownership change
4:41pm
3
Julie VanOrsdel Daves
15 Sep 22
DiaMedica Therapeutics / Julie VanOrsdel Daves ownership change
4:15pm
S-8
DMAC
DiaMedica Therapeutics Inc
11 Aug 22
Registration of securities for employees
4:39pm
10-Q
2022 Q2
DMAC
DiaMedica Therapeutics Inc
Quarterly report
10 Aug 22
5:37pm
8-K
DMAC
DiaMedica Therapeutics Inc
10 Aug 22
DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2022 Financial Results
5:22pm
4
Koch Thomas Von
21 Jul 22
DiaMedica Therapeutics / AB TomEnterprise ownership change
1:06pm
3
TomEnterprise AB
21 Jul 22
DiaMedica Therapeutics / AB TomEnterprise ownership change
1:03pm
SC 13G/A
DMAC
DiaMedica Therapeutics Inc
12 Jul 22
DiaMedica Therapeutics / TomEnterprise AB ownership change
1:24pm
8-K
DMAC
DiaMedica Therapeutics Inc
6 Jul 22
DiaMedica Therapeutics Announces Clinical Hold of its Phase 2/3 ReMEDy2 Clinical Trial for DM199
4:30pm
8-K
DMAC
DiaMedica Therapeutics Inc
29 Jun 22
Entry into a Material Definitive Agreement
4:30pm